X

Trial Profile

A comparative study of ticagrelor verses clopidogrel in patients with acute myocardial-infarction

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 19 Sep 2017

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Clopidogrel (Primary) ; Ticagrelor (Primary)
Indications Myocardial infarction
Focus Therapeutic Use

Most Recent Events

30 Aug 2017 Results presented at the 33rd International Conference on Pharmacoepidemiology and Therapeutic Risk Management
21 Dec 2016 New trial record
16 Nov 2016 Primary endpoint (All-cause death, recurrent MI or ischemic stroke) has been met according to the results presented at the 89th Annual Scientific Sessions of the American Heart Association

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com